• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

疟原虫氯喹抗性转运蛋白(PfCRT)和疟原虫多重耐药蛋白1(PfMDR1)调节青蒿素衍生物与离子通道阻滞剂的相互作用。

PfCRT and PfMDR1 modulate interactions of artemisinin derivatives and ion channel blockers.

作者信息

Eastman Richard T, Khine Pwint, Huang Ruili, Thomas Craig J, Su Xin-Zhuan

机构信息

Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.

Division of Preclinical Development, National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, Maryland, USA.

出版信息

Sci Rep. 2016 May 5;6:25379. doi: 10.1038/srep25379.

DOI:10.1038/srep25379
PMID:27147113
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4857081/
Abstract

Treatment of the symptomatic asexual stage of Plasmodium falciparum relies almost exclusively on artemisinin (ART) combination therapies (ACTs) in endemic regions. ACTs combine ART or its derivative with a long-acting partner drug to maximize efficacy during the typical three-day regimen. Both laboratory and clinical studies have previously demonstrated that the common drug resistance determinants P. falciparum chloroquine resistance transporter (PfCRT) and multidrug resistance transporter (PfMDR1) can modulate the susceptibility to many current antimalarial drugs and chemical compounds. Here we investigated the parasite responses to dihydroartemisinin (DHA) and various Ca(2+) and Na(+) channel blockers and showed positively correlated responses between DHA and several channel blockers, suggesting potential shared transport pathways or mode of action. Additionally, we demonstrated that PfCRT and PfMDR1 could also significantly modulate the pharmacodynamic interactions of the compounds and that the interactions were influenced by the parasite genetic backgrounds. These results provide important information for better understanding of drug resistance and for assessing the overall impact of drug resistance markers on parasite response to ACTs.

摘要

在疟疾流行地区,恶性疟原虫有症状无性阶段的治疗几乎完全依赖于青蒿素(ART)联合疗法(ACTs)。ACTs将青蒿素或其衍生物与一种长效辅助药物联合使用,以在典型的三天疗程中最大限度地提高疗效。此前,实验室和临床研究均已证明,常见的耐药性决定因素——恶性疟原虫氯喹抗性转运蛋白(PfCRT)和多药抗性转运蛋白(PfMDR1)——可调节对许多当前抗疟药物和化合物的敏感性。在此,我们研究了疟原虫对双氢青蒿素(DHA)以及各种钙(Ca2+)和钠(Na+)通道阻滞剂的反应,结果显示DHA与几种通道阻滞剂之间存在正相关反应,这表明可能存在共同的转运途径或作用方式。此外,我们还证明PfCRT和PfMDR1也可显著调节这些化合物的药效学相互作用,且这种相互作用受疟原虫遗传背景的影响。这些结果为更好地理解耐药性以及评估耐药性标志物对疟原虫对ACTs反应的总体影响提供了重要信息。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a781/4857081/7bd2dca7304f/srep25379-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a781/4857081/627597ef0ccb/srep25379-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a781/4857081/d1382ae554bf/srep25379-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a781/4857081/baac97480c31/srep25379-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a781/4857081/6a43fff9cdf6/srep25379-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a781/4857081/be0af31ec79a/srep25379-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a781/4857081/7bd2dca7304f/srep25379-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a781/4857081/627597ef0ccb/srep25379-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a781/4857081/d1382ae554bf/srep25379-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a781/4857081/baac97480c31/srep25379-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a781/4857081/6a43fff9cdf6/srep25379-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a781/4857081/be0af31ec79a/srep25379-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a781/4857081/7bd2dca7304f/srep25379-f6.jpg

相似文献

1
PfCRT and PfMDR1 modulate interactions of artemisinin derivatives and ion channel blockers.疟原虫氯喹抗性转运蛋白(PfCRT)和疟原虫多重耐药蛋白1(PfMDR1)调节青蒿素衍生物与离子通道阻滞剂的相互作用。
Sci Rep. 2016 May 5;6:25379. doi: 10.1038/srep25379.
2
A Variant PfCRT Isoform Can Contribute to Resistance to the First-Line Partner Drug Piperaquine.一种变异的疟原虫氯喹抗性转运蛋白(PfCRT)异构体可能导致对一线联合用药磷酸哌喹产生耐药性。
mBio. 2017 May 9;8(3):e00303-17. doi: 10.1128/mBio.00303-17.
3
A 2-amino quinoline, 5-(3-(2-(7-chloroquinolin-2-yl)ethenyl)phenyl)-8-dimethylcarbamyl-4,6-dithiaoctanoic acid, interacts with PfMDR1 and inhibits its drug transport in Plasmodium falciparum.一种2-氨基喹啉,5-(3-(2-(7-氯喹啉-2-基)乙烯基)苯基)-8-二甲基氨基甲酰基-4,6-二硫代辛酸,与恶性疟原虫的PfMDR1相互作用并抑制其药物转运。
Mol Biochem Parasitol. 2014 Jun;195(1):34-42. doi: 10.1016/j.molbiopara.2014.05.006. Epub 2014 Jun 8.
4
Monitoring of in vitro susceptibilities and molecular markers of resistance of Plasmodium falciparum isolates from Thai-Myanmar border to chloroquine, quinine, mefloquine and artesunate.监测来自泰缅边境地区恶性疟原虫分离株对氯喹、奎宁、甲氟喹和青蒿琥酯的体外敏感性和耐药性分子标志物。
Acta Trop. 2010 Feb;113(2):190-4. doi: 10.1016/j.actatropica.2009.10.016. Epub 2009 Oct 30.
5
In vitro selection of Plasmodium falciparum Pfcrt and Pfmdr1 variants by artemisinin.青蒿素对恶性疟原虫Pfcrt和Pfmdr1变体的体外筛选
Malar J. 2016 Jul 22;15(1):381. doi: 10.1186/s12936-016-1443-y.
6
Transporters involved in resistance to antimalarial drugs.参与抗疟药物耐药性的转运蛋白。
Trends Pharmacol Sci. 2006 Nov;27(11):594-601. doi: 10.1016/j.tips.2006.09.005. Epub 2006 Sep 25.
7
Molecular Surveillance of Drug Resistance of Plasmodium falciparum Isolates Imported from Angola in Henan Province, China.中国河南省从安哥拉输入疟原虫分离株的耐药性分子监测。
Antimicrob Agents Chemother. 2019 Sep 23;63(10). doi: 10.1128/AAC.00552-19. Print 2019 Oct.
8
Evidence for Regulation of Hemoglobin Metabolism and Intracellular Ionic Flux by the Plasmodium falciparum Chloroquine Resistance Transporter.疟原虫氯喹耐药转运蛋白对血红蛋白代谢和细胞内离子流的调控作用的证据。
Sci Rep. 2018 Sep 11;8(1):13578. doi: 10.1038/s41598-018-31715-9.
9
In Vitro and Molecular Surveillance for Antimalarial Drug Resistance in Plasmodium falciparum Parasites in Western Kenya Reveals Sustained Artemisinin Sensitivity and Increased Chloroquine Sensitivity.肯尼亚西部恶性疟原虫对抗疟药物耐药性的体外和分子监测显示青蒿素敏感性持续存在且氯喹敏感性增加。
Antimicrob Agents Chemother. 2015 Dec;59(12):7540-7. doi: 10.1128/AAC.01894-15. Epub 2015 Sep 21.
10
Mapping partner drug resistance to guide antimalarial combination therapy policies in sub-Saharan Africa.绘制伙伴药物耐药性图谱以指导撒哈拉以南非洲的抗疟联合治疗政策。
Proc Natl Acad Sci U S A. 2021 Jul 20;118(29). doi: 10.1073/pnas.2100685118.

引用本文的文献

1
Antagonistic antimalarial properties of a methoxyamino chalcone derivative and 3-hydroxypyridinones in combination with dihydroartemisinin against .甲氧基氨基查尔酮衍生物和 3-羟基吡啶酮与双氢青蒿素联合的抗疟原虫拮抗作用。
PeerJ. 2023 Apr 27;11:e15187. doi: 10.7717/peerj.15187. eCollection 2023.
2
A Plasmodium falciparum RING Finger E3 Ubiquitin Ligase Modifies the Roles of PfMDR1 and PfCRT in Parasite Drug Responses.恶性疟原虫 RING 指 E3 泛素连接酶修饰 PfMDR1 和 PfCRT 在寄生虫药物反应中的作用。
Antimicrob Agents Chemother. 2023 Feb 16;67(2):e0082122. doi: 10.1128/aac.00821-22. Epub 2023 Jan 10.
3
Mechanistic basis for multidrug resistance and collateral drug sensitivity conferred to the malaria parasite by polymorphisms in PfMDR1 and PfCRT.

本文引用的文献

1
Haem-activated promiscuous targeting of artemisinin in Plasmodium falciparum.血红素激活青蒿素对恶性疟原虫的混杂靶向作用。
Nat Commun. 2015 Dec 22;6:10111. doi: 10.1038/ncomms10111.
2
An integrative analysis of small molecule transcriptional responses in the human malaria parasite Plasmodium falciparum.对人类疟原虫恶性疟原虫中小分子转录反应的综合分析。
BMC Genomics. 2015 Dec 4;16:1030. doi: 10.1186/s12864-015-2165-1.
3
Chemogenomic profiling of Plasmodium falciparum as a tool to aid antimalarial drug discovery.恶性疟原虫的化学基因组学分析作为辅助抗疟药物发现的工具
PfMDR1 和 PfCRT 多态性赋予疟原虫多药耐药和交叉药物敏感性的机制基础。
PLoS Biol. 2022 May 4;20(5):e3001616. doi: 10.1371/journal.pbio.3001616. eCollection 2022 May.
4
Malaria-associated adhesion molecule activation facilitates the destruction of uninfected red blood cells.疟原虫相关黏附分子的激活促进了未感染红细胞的破坏。
Blood Adv. 2022 Nov 8;6(21):5798-5810. doi: 10.1182/bloodadvances.2021006171.
5
Machine learning for artemisinin resistance in malaria treatment across platforms.跨平台疟疾治疗中青蒿素耐药性的机器学习
iScience. 2022 Feb 10;25(3):103910. doi: 10.1016/j.isci.2022.103910. eCollection 2022 Mar 18.
6
Artemisinin resistance-associated markers in Plasmodium falciparum parasites from the China-Myanmar border: predicted structural stability of K13 propeller variants detected in a low-prevalence area.来自中缅边境地区恶性疟原虫中的青蒿素耐药相关标记物:在低流行地区检测到的 K13 螺旋桨变异体的预测结构稳定性。
PLoS One. 2019 Mar 18;14(3):e0213686. doi: 10.1371/journal.pone.0213686. eCollection 2019.
7
Current scenario and future strategies to fight artemisinin resistance.对抗青蒿素耐药性的当前情况及未来策略
Parasitol Res. 2019 Jan;118(1):29-42. doi: 10.1007/s00436-018-6126-x. Epub 2018 Nov 26.
8
Chemotherapeutic efficacies of a clofazimine and diminazene aceturate combination against piroplasm parasites and their AT-rich DNA-binding activity on Babesia bovis.氯法齐明和乙酰苯肼联合用药对梨形虫寄生虫的化疗效果及其对牛巴贝斯虫的富含 AT 的 DNA 结合活性。
Sci Rep. 2017 Oct 24;7(1):13888. doi: 10.1038/s41598-017-14304-0.
9
High throughput resistance profiling of Plasmodium falciparum infections based on custom dual indexing and Illumina next generation sequencing-technology.基于定制双索引和 Illumina 新一代测序技术的恶性疟原虫感染高通量耐药分析。
Sci Rep. 2017 May 25;7(1):2398. doi: 10.1038/s41598-017-02724-x.
10
Molecular Mechanisms for Drug Hypersensitivity Induced by the Malaria Parasite's Chloroquine Resistance Transporter.疟原虫氯喹抗性转运蛋白诱导药物超敏反应的分子机制
PLoS Pathog. 2016 Jul 21;12(7):e1005725. doi: 10.1371/journal.ppat.1005725. eCollection 2016 Jul.
Sci Rep. 2015 Nov 6;5:15930. doi: 10.1038/srep15930.
4
High-throughput matrix screening identifies synergistic and antagonistic antimalarial drug combinations.高通量矩阵筛选可识别协同和拮抗的抗疟药物组合。
Sci Rep. 2015 Sep 25;5:13891. doi: 10.1038/srep13891.
5
A molecular mechanism of artemisinin resistance in Plasmodium falciparum malaria.恶性疟原虫疟疾中青蒿素耐药性的分子机制。
Nature. 2015 Apr 30;520(7549):683-7. doi: 10.1038/nature14412. Epub 2015 Apr 15.
6
Predicting functional and regulatory divergence of a drug resistance transporter gene in the human malaria parasite.预测人类疟原虫中一种耐药转运蛋白基因的功能和调控差异。
BMC Genomics. 2015 Feb 22;16(1):115. doi: 10.1186/s12864-015-1261-6.
7
Genetic architecture of artemisinin-resistant Plasmodium falciparum.青蒿素抗性恶性疟原虫的遗传结构
Nat Genet. 2015 Mar;47(3):226-34. doi: 10.1038/ng.3189. Epub 2015 Jan 19.
8
Drug resistance. K13-propeller mutations confer artemisinin resistance in Plasmodium falciparum clinical isolates.耐药性。K13 桨叶突变赋予疟原虫临床分离株对青蒿素的耐药性。
Science. 2015 Jan 23;347(6220):428-31. doi: 10.1126/science.1260867. Epub 2014 Dec 11.
9
In vivo selection of Plasmodium falciparum Pfcrt and Pfmdr1 variants by artemether-lumefantrine and dihydroartemisinin-piperaquine in Burkina Faso.在布基纳法索,蒿甲醚-本芴醇和双氢青蒿素-哌喹对恶性疟原虫Pfcrt和Pfmdr1变体的体内选择
Antimicrob Agents Chemother. 2015 Jan;59(1):734-7. doi: 10.1128/AAC.03647-14. Epub 2014 Nov 17.
10
Polymorphisms in Plasmodium falciparum chloroquine resistance transporter and multidrug resistance 1 genes: parasite risk factors that affect treatment outcomes for P. falciparum malaria after artemether-lumefantrine and artesunate-amodiaquine.疟原虫氯喹耐药转运体和多药耐药基因 1 多态性:影响青蒿琥酯-咯萘啶和青蒿琥酯-阿莫地喹治疗恶性疟原虫疟疾后治疗结局的寄生虫危险因素。
Am J Trop Med Hyg. 2014 Oct;91(4):833-843. doi: 10.4269/ajtmh.14-0031. Epub 2014 Jul 21.